Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes

Increasing evidence indicates that native mu and delta opioid receptors can associate to form heteromers in discrete brain neuronal circuits. However, little is known about their signaling and trafficking. Using double-fluorescent knock-in mice, we investigated the impact of neuronal co-expression on the internalization profile of mu and delta opioid receptors in primary hippocampal cultures. We established ligand selective mu–delta co-internalization upon activation by 1-[[4-(acetylamino)phenyl]methyl]-4-(2-phenylethyl)-4-piperidinecarboxylic acid, ethyl ester (CYM51010), [d-Ala2, NMe-Phe4, Gly-ol5]enkephalin (DAMGO), and deltorphin II, but not (+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80), morphine, or methadone. Co-internalization was driven by the delta opioid receptor, required an active conformation of both receptors, and led to sorting to the lysosomal compartment. Altogether, our data indicate that mu–delta co-expression, likely through heteromerization, alters the intracellular fate of the mu opioid receptor, which provides a way to fine-tune mu opioid receptor signaling. It also represents an interesting emerging concept for the development of novel therapeutic drugs and strategies.

[1]  Shaoqiu He,et al.  Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents. , 2019, Pain.

[2]  P. Veinante,et al.  Morphine-dependent and abstinent mice are characterized by a broader distribution of the neurons co-expressing mu and delta opioid receptors , 2019, Neuropharmacology.

[3]  M. Barrot,et al.  Peripheral delta opioid receptors mediate duloxetine antiallodynic effect in a mouse model of neuropathic pain , 2018, The European journal of neuroscience.

[4]  A. Basbaum,et al.  Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits , 2018, Neuron.

[5]  P. Dallaire,et al.  Analyzing biased responses of GPCR ligands. , 2017, Current opinion in pharmacology.

[6]  G. Sanger,et al.  Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design , 2016, Scientific Reports.

[7]  P. Sexton,et al.  Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor. , 2016, Biochemical pharmacology.

[8]  J. Vonesch,et al.  Impact of chronic morphine on delta opioid receptor-expressing neurons in the mouse hippocampus , 2016, Neuroscience.

[9]  D. Filliol,et al.  A Novel Anxiogenic Role for the Delta Opioid Receptor Expressed in GABAergic Forebrain Neurons , 2015, Biological Psychiatry.

[10]  D. Massotte,et al.  Fluorescent knock-in mice to decipher the physiopathological role of G protein-coupled receptors , 2015, Front. Pharmacol..

[11]  L. Gendron,et al.  Recent advances on the δ opioid receptor: from trafficking to function , 2015, British journal of pharmacology.

[12]  L. Devi,et al.  Heteromers of μ‐δ opioid receptors: new pharmacology and novel therapeutic possibilities , 2015, British journal of pharmacology.

[13]  L. Devi,et al.  Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR Review 10 , 2014, British journal of pharmacology.

[14]  M. Olmstead,et al.  Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking , 2014, British journal of pharmacology.

[15]  L. Trudeau,et al.  Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists , 2014, Cellular and Molecular Life Sciences.

[16]  P. Veinante,et al.  A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks , 2014, Brain Structure and Function.

[17]  K. Befort,et al.  15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse , 2014, Neuropharmacology.

[18]  B. Balleine,et al.  Learning-Related Translocation of δ-Opioid Receptors on Ventral Striatal Cholinergic Interneurons Mediates Choice between Goal-Directed Actions , 2013, The Journal of Neuroscience.

[19]  L. Devi,et al.  Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity , 2013, Proceedings of the National Academy of Sciences.

[20]  J. Vonesch,et al.  In Vivo Visualization of Delta Opioid Receptors upon Physiological Activation Uncovers a Distinct Internalization Profile , 2012, The Journal of Neuroscience.

[21]  Ying Xia,et al.  Current research on opioid receptor function. , 2012, Current drug targets.

[22]  J. Whistler,et al.  Heteromerization of the μ- and δ-Opioid Receptors Produces Ligand-Biased Antagonism and Alters μ-Receptor Trafficking , 2011, Journal of Pharmacology and Experimental Therapeutics.

[23]  Shaoqiu He,et al.  Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation , 2011, Neuron.

[24]  G. Balboni,et al.  Agonists at the δ‐opioid receptor modify the binding of µ‐receptor agonists to the µ–δ receptor hetero‐oligomer , 2010, British journal of pharmacology.

[25]  J. Traynor,et al.  G Protein independent phosphorylation and internalization of the δ‐opioid receptor , 2009, Journal of neurochemistry.

[26]  D. Filliol,et al.  In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists , 2009, PloS one.

[27]  B. O'dowd,et al.  Trafficking of preassembled opioid μ-δ heterooligomer-Gz signaling complexes to the plasma membrane: Coregulation by agonists , 2007 .

[28]  L. Devi,et al.  Receptor heterodimerization leads to a switch in signaling: β‐arrestin2‐mediated ERK activation by μ‐δ opioid receptor heterodimers , 2007 .

[29]  Michel Bouvier,et al.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers , 2007, Pharmacological Reviews.

[30]  A. Basbaum,et al.  Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Burbach,et al.  Receptor‐selective changes in µ‐, δ‐ and κ‐opioid receptors after chronic naltrexone treatment in mice , 2003, The European journal of neuroscience.

[32]  Jean-Christophe Olivo-Marin,et al.  Extraction of spots in biological images using multiscale products , 2002, Pattern Recognit..

[33]  M. von Zastrow,et al.  Modulation of Postendocytic Sorting of G Protein-Coupled Receptors , 2002, Science.

[34]  D. Filliol,et al.  Quantitative autoradiographic mapping of opioid receptors in the brain of δ-opioid receptor gene knockout mice , 2002, Brain Research.

[35]  C. Gaveriaux-Ruff,et al.  Opioid receptor genes inactivated in mice: the highlights , 2002, Neuropeptides.

[36]  A. Basbaum,et al.  Postsynaptic Signaling via the μ-Opioid Receptor: Responses of Dorsal Horn Neurons to Exogenous Opioids and Noxious Stimulation , 2000, The Journal of Neuroscience.

[37]  L. Devi,et al.  Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  H. Loh,et al.  Deltorphin II-induced Rapid Desensitization of δ-Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor* , 2000, The Journal of Biological Chemistry.

[39]  S. Salvadori,et al.  Further Studies on the Dmt-Tic Pharmacophore: Hydrophobic Substituents at the C-Terminus Endow δ Antagonists To Manifest μ Agonism or μ Antagonism , 1999 .

[40]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[41]  D. Massotte,et al.  Double Fluorescent Knock-In Mice to Investigate Endogenous Mu-Delta Opioid Heteromer Subcellular Distribution , 2018 .

[42]  B. O'dowd,et al.  Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. , 2007, Biochemistry.

[43]  L. Devi,et al.  Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  S. Salvadori,et al.  Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. , 1999, Journal of Medicinal Chemistry.

[45]  H. Matthes,et al.  Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. , 1997, Brain research.